Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-28Clinical Trial Update: Bevacizumab in Recurrent Grade II and III Glioma [Phase 2]
Phase 2 clinical trial update evaluating bevacizumab for recurrent grade II and III glioma has been completed.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 study of intraventricular liposomal cytarabine (DepoCyt) for recurrent glioblastoma was terminated, and results have been posted…
-
CLINICAL_TRIALS trial_result · 2019-02-06Clinical Trial Update: Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating repeat radiation, minocycline, and bevacizumab in patients with recurrent glioma has completed with resu…
-
CLINICAL_TRIALS withdrawal · 2019-02-06Clinical Trial Update: Confocal Laser Endomicroscopy (CLE) During Medically Induced Neurosurgery in Craniobasal and Glioma Tumours
The clinical trial evaluating Confocal Laser Endomicroscopy during medically induced neurosurgery for glioma and related brain tumors has be…
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas [Phase 1, Phase 2]
Phase I/II trial of intramural DTI-015 for recurrent malignant gliomas has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Safety of BBB Opening With the SonoCloud [Phase 1, Phase 2]
Phase 1/2 trial update on safety of SonoCloud-induced BBB opening for glioblastoma and glioma patients; study completed.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: PVSRIPO for Recurrent Glioblastoma (GBM) [Phase 1]
Phase 1 clinical trial update for PVSRIPO in recurrent glioblastoma (GBM) completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: GW572016 to Treat Recurrent Malignant Brain Tumors [Phase 2]
Phase 2 trial of GW572016 (lapatinib) for recurrent malignant brain tumors has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas [Phase 2]
A Phase 2 trial of crenolanib for adult gliomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma [Phase 1]
This is a terminated Phase 1 open-label study evaluating convection-enhanced delivery of IL-13-PE38QQR in pediatric diffuse infiltrating bra…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Plerixafor After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed High Grade Glioma [Phase 1, Phase 2]
Phase 1/2 clinical trial assessing plerixafor after radiation therapy and temozolomide in newly diagnosed high-grade glioma has completed wi…
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
A completed clinical trial update examining factors associated with the development of blood clots in patients undergoing treatment for newl…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy [Phase 1, Phase 2]
Clinical trial update for SU5416 (Semaxanib) in patients with recurrent astrocytoma or mixed glioma after radiation failure; the Phase 1/2 s…
-
CLINICAL_TRIALS trial_result · 2018-06-26Clinical Trial Update: Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide [Phase 2]
Phase 2 trial comparing aprepitant (Emend) plus ondansetron versus ondansetron alone to prevent chemotherapy-induced nausea and vomiting in …
-
CLINICAL_TRIALS research · 2018-06-07Clinical Trial Update: Early-Phase Study to Assess Inhibitor Ribociclib in Patients With Recurrent Glioblastoma or Anaplastic Glioma [Phase 1]
Phase 1 clinical trial update evaluating the CDK4/6 inhibitor ribociclib in patients with recurrent glioblastoma or anaplastic glioma.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Carbon Ion Radiotherapy for Recurrent Gliomas [NA]
The clinical trial evaluating carbon ion radiotherapy for recurrent gliomas has completed.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors [NA]
Clinical trial update reporting completed results for PET imaging using [18F] FACBC and [18F] FLT in patients with brain cancer and gliomas.
-
CLINICAL_TRIALS trial_result · 2018-04-09Clinical Trial Update: MRS and 11C-methionine PET/CT in the Diagnosis of Glioma [NA]
A completed clinical trial evaluating magnetic resonance spectroscopy and 11C-methionine PET/CT for diagnosing glioma.
-
CLINICAL_TRIALS trial_result · 2018-04-05Clinical Trial Update: Interdisciplinary Rehabilitation of Patients With Glioma During Anti-cancer Treatment [NA]
A completed clinical trial assessing interdisciplinary rehabilitation for glioma patients during anti-cancer treatment.
-
CLINICAL_TRIALS trial_result · 2018-03-07Clinical Trial Update: Temozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma [Phase 2]
Phase 2 trial in glioblastoma comparing dose-dense temozolomide after chemoradiation to temozolomide with all-trans retinoic acid; results p…
-
CLINICAL_TRIALS trial_result · 2018-01-26Clinical Trial Update: Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma [Phase 2]
Phase 2 trial update evaluating Tc-99m tetrofosmin for differentiating glioma recurrence from radiation necrosis.
-
CLINICAL_TRIALS trial_result · 2018-01-04Clinical Trial Update: A Study of Apatinib in Recurrent or Recurrent High-grade Glioma [Phase 2]
Phase 2 trial investigating apatinib in patients with recurrent high-grade glioma.
-
CLINICAL_TRIALS research · 2017-11-28Clinical Trial Update: Multimodality Imaging Combined With Multiple Targets Pathological Examination for Detecting of Biological Borders of Gliomas: a Clinical Application Study [NA]
A clinical trial update on using multimodality imaging with multiple-target pathology to detect the biological borders of Glioma in a clinic…
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 [Phase 1]
A Phase 1 trial evaluating an autologous heat shock protein gp96 vaccine for glioblastoma/glioma has completed.
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Temozolomide and Radiation Therapy in Treating Patients With Gliomas [Phase 2]
A Phase 2 clinical trial evaluating the combination of temozolomide and radiation therapy for gliomas has completed, with results posted.